KO
Kopran Ltd (KOPRAN)
₹282.05
Mkt cap
₹1,342 Cr
P/E ratio
53.70
P/B
2.56
Div yield
1.08%
ROE
4.91%
ROCE
6.65%
EPS (TTM)
₹5.25
Book value
₹110
52W range
107–296
Sector
Healthcare
Price history
Previous close
Kopran Ltd. is a fully integrated pharmaceutical company that manufactures and supplies high-quality formulations and active pharmaceutical ingredients globally.
NSE KOPRANBSE 524280
Health check
Cautious
ValuationExpensive
ProfitabilityWeak
GrowthModerate
TechnicalsBullish
52-week range
−4.66% from high₹282
₹107+163.60% from low₹296
Current
₹282.05
Prev close
₹278.32
Day
+1.34%
Price performance
1D
+1.66%
1W
+4.48%
1M
+30.04%
3M
+46.37%
6M
+161.89%
1Y
+54.82%
YTD
+85.46%
Financials
Revenue, profit & margin
P/E ratio
53.7×
KOPRAN is 55% above the sector median of 34.6×
KOPRAN53.7×
Sector median34.6×
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 117.00 | 152.59 | 158.92 | 186.08 | 139.44 | 151.56 | 166.24 | 172.36 | 135.22 | 117.91 | 194.28 | 234.02 | 153.99 | |
| Expenses | 110.69 | 129.76 | 135.34 | 164.39 | 121.28 | 136.83 | 146.39 | 155.27 | 121.09 | 123.19 | 176.52 | 201.08 | 138.18 | |
| Operating Profit | 6.31 | 22.83 | 23.58 | 21.69 | 18.16 | 14.73 | 19.85 | 17.09 | 14.13 | -5.28 | 17.76 | 32.94 | 15.81 | |
| OPM % | 5.39% | 14.96% | 14.84% | 11.66% | 13.02% | 9.72% | 11.94% | 9.92% | 10.45% | -4.48% | 9.14% | 14.08% | 10.27% | |
| Other Income | 2.39 | 0.13 | 2.43 | 9.67 | 2.63 | 1.00 | 0.17 | 3.26 | 2.56 | 0.03 | 0.07 | 0.09 | 2.05 | |
| Interest | 1.83 | 1.94 | 2.24 | 2.59 | 2.18 | 2.23 | 2.16 | 2.77 | 2.54 | 2.09 | 2.67 | 3.17 | 3.28 | |
| Depreciation | 3.26 | 2.77 | 3.27 | 3.59 | 3.87 | 3.85 | 4.00 | 3.87 | 4.26 | 4.28 | 4.42 | 4.52 | 5.77 | |
| Profit before tax | 3.61 | 18.25 | 20.50 | 25.18 | 14.74 | 9.65 | 13.86 | 13.71 | 9.89 | -11.62 | 10.74 | 25.34 | 8.81 | |
| Tax % | 22.99% | 24.55% | 23.02% | 26.01% | 24.69% | 23.42% | 24.96% | 29.39% | 24.67% | -14.63% | 13.04% | 25.57% | 23.84% | |
| Net Profit | 2.77 | 13.77 | 15.79 | 18.62 | 11.10 | 7.38 | 10.40 | 9.68 | 7.45 | -9.92 | 9.34 | 18.87 | 6.70 | |
| EPS in Rs | 0.57 | 2.86 | 3.28 | 3.86 | 2.30 | 1.53 | 2.16 | 2.01 | 1.54 | -2.06 | 1.94 | 3.91 | 1.39 | |
| Raw PDF |
Earnings
Results dates & reactionsNo upcoming results date on calendar.
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
Avg earnings-day move −4.95% · closed higher next day 0 of last 1
| Q1FY27 | |
|---|---|
| Broadcast | 7 Aug '26 |
| Earnings day | −4.95% |
| +1 day | −6.79% |
| +5 days | −0.24% |
| +15 days | +5.82% |
| +30 days | +48.42% |
| Filing | XBRL |
Corporate actions
Last 6 monthsNo recent corporate actions
Dividends, splits, and bonuses in the last six months show up here.
Results analysis
Shareholding
as of Jun 202644.43%Promoter
Promoters44.43%
FIIs0.51%0.06
DIIs0.00%
Public55.06%0.05
Ownership trend
Peers
8 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| Sun Pharma.Inds. | ₹1,837.30 | 34.90 | 4,40,830 | 0.87% | 2,901 | +5.95% | 15,300 | +10.46% | 20.53% |
| Divi's Lab. | ₹9,375.00 | 83.54 | 2,48,877 | 0.32% | 902 | +65.50% | 3,080 | +27.80% | 21.97% |
| Torrent Pharma. | ₹4,840.00 | 82.51 | 1,84,098 | 0.79% | 566 | +5.79% | 4,921 | +54.85% | 15.19% |
| Zydus Lifesci. | ₹1,160.00 | 23.77 | 1,15,710 | 0.09% | 990 | −35.09% | 8,017 | +21.96% | 21.14% |
| Cipla | ₹1,394.50 | 31.48 | 1,12,656 | 0.93% | 786 | −39.19% | 7,119 | +2.33% | 15.49% |
| Laurus Labs | ₹1,954.00 | 96.56 | 1,05,577 | 0.10% | 362 | +125.49% | 2,026 | +29.10% | 17.76% |
| Aurobindo Pharma | ₹1,734.00 | 26.39 | 99,771 | 0.23% | 1,032 | +28.11% | 9,150 | +16.30% | 12.86% |
| Kopran | ₹277.60 | 53.68 | 1,342 | 1.08% | 7 | −10.07% | 154 | +13.88% | 6.65% |
| Median: 158 Co. | ₹433.90 | 34.56 | 2,205 | 0.08% | 13 | +29.57% | 164 | +18.57% | 14.96% |
Filings
Annual reports15
Concall transcripts29
PPTAug 2026PPTMay 2026PPTJan 2026PPTNov 2025PPTNov 2025PPTJul 2025PPTMay 2025TranscriptMar 2025TranscriptFeb 2025TranscriptFeb 2025PPTFeb 2025TranscriptNov 2024PPTNov 2024RECNov 2024TranscriptAug 2024TranscriptAug 2024PPTAug 2024TranscriptMay 2024PPTMay 2024TranscriptFeb 2024PPTFeb 2024PPTFeb 2024TranscriptNov 2023PPTNov 2023
Credit ratings6
Announcements5
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS 16 SepDisclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011 8 Sep - United Shippers sold 12 lakh Kopran shares, reducing holding to 10 lakh shares.Clarification For Increase In Scrip Volume 1 Sep - September 1, 2026: Kopran says volume spike is market-driven, with no undisclosed material information.Clarification sought from Kopran Ltd 1 Sep - Exchange has sought clarification from Kopran Ltd on September 01, 2026, with reference to Movement in Volume.Shareholder Meeting / Postal Ballot-Outcome of AGM 18 Aug